Clinical Trial Update: Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing nab-paclitaxel with trastuzumab and pertuzumab (Nab-PHP) versus a taxane-based regimen with trastuzumab and pertuzumab (TCbHP…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Nab-paclitaxel (paclitaxel protein-bound)
• PACLITAXEL (PACLITAXEL)
• Pertuzumab (pertuzumab)
• Trastuzumab (trastuzumab)

Snippet

Sponsor: Henan Cancer Hospital | Conditions: Breast Cancer | Phase 3 | Status: RECRUITING